DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Powell CA, Camidge DR, Gemma A. et al.
Characterization, monitoring, and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload.
San Antonio Breast Cancer Symposium 2018 Abstr. P6-17-06
Access:
We do not assume any responsibility for the contents of the web pages of other providers.